Updated 10 November 2026.
At The Check Up 2026, Google announced health AI updates including a $10 million investment to train future clinicians in using AI, upgrades to Search and Fitbit health features, and broader work across health AI and research. Google Research framed its Check Up work as moving from healthcare innovation to real-world care settings.
The announcements illustrate an increasingly important distinction: consumer health AI and professional clinical AI are diverging into separate product categories with different risk profiles, different governance requirements, and different evidence standards — even when they use similar underlying models.
The Same Model, Very Different Products
A related model family can support consumer information, professional reference, training and organisational tasks. That does not mean the resulting products use an identical model or share their sources, permissions, terms or clinical evidence. Compare the named product and configured function rather than assume that a company-wide model label establishes equivalent behaviour.
Consumer Health AI Risk Profile
Consumer health AI faces specific risks: false reassurance (a patient with serious symptoms receiving an AI summary that normalises their concern), oversimplification (complex clinical conditions reduced to a paragraph that omits critical nuance), missing red flags (AI-generated health advice that does not prompt the user to seek urgent care), lack of clinical context (the AI does not know the patient's medications, allergies, comorbidities, or clinical history), poor geography alignment (US-centric health advice shown to UK users), and delayed care (patients using AI health information as a substitute for professional consultation).
Professional Clinical AI Risk Profile
Professional clinical AI faces different risks: source fidelity (does the answer remain faithful to the guideline or SmPC?), prescribing accuracy (are drug names, doses, and contraindications correct?), guideline concordance (does the answer align with current UK recommendations?), auditability (can the provenance of every claim be traced?), governance (is the tool used within an appropriate regulatory and professional framework?), and professional responsibility (does the clinician retain decision-making authority?).
The risks are different because the users are different. A consumer may act on health AI advice without professional verification. A clinician is expected to verify, contextualise, and apply professional judgement — but only if the tool's design supports that verification process.
Where iatroX Fits
iatroX is deliberately professional-facing. It is designed for clinicians and healthcare professionals who can interpret, verify, and apply clinical information within a professional framework. Its trust architecture — source-grounded retrieval, provenance, fidelity controls, fail-safe behaviour, and feedback — reflects that professional context.
Use iatroX for professional clinical questions where source verification matters →
Later product context added 10 November 2026
The Gemini healthcare launch explainer addresses a later organisational offering. Keep it separate from the historical Check Up announcements discussed here. For clinicians choosing a daily tool, iatroX's practical reference-and-learning journey can serve a different purpose from the organisation's wider workflow technology.